Component
Human glutathione S-transferase A1
Human glutathione S-transferase A1. Species, exposure and limitations are retained in each linked claim.
5 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
GSTA1 showed only low-affinity xanthophyll binding in the comparison.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/zeaxanthin-research/15355982.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "6365b1d54aafda71be4dbf6c8e5252fa6ce0af3b808d9af6fe07c37ae188ea92", "start_char": 0, "end_char": 1907, "text_sha256": "6365b1d54aafda71be4dbf6c8e5252fa6ce0af3b808d9af6fe07c37ae188ea92"}
- experimental_model
- Human macular protein purification and recombinant binding
- exposure
- Equilibrium binding and immunocytochemistry
- limitations
- Binding affinity is assay-specific and does not quantify uptake or clinical benefit.
- nutrient_topic
- Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. · Dietary (3R,3-prime-R)-zeaxanthin
- organism
- Human tissue/proteins
- plain_language
- Membership in the GST family does not guarantee selective binding.
- primary_references
- [zeaxanthin-p15355982] Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. (2004). https://pubmed.ncbi.nlm.nih.gov/15355982/ DOI: 10.1074/jbc.m405334200
- tissue_or_cell_type
- Macula and purified proteins
Zeaxanthin: metabolism, signaling and nutrient connections (2026-09-17) · lines 236–247
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human macular protein purification and recombinant binding · source_derived_draft · unverified_draft
### zeaxanthin-gsta1-low GSTA1 showed only low-affinity xanthophyll binding in the comparison. Condition category: normal nutrient_topic: Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Membership in the GST family does not guarantee selective binding. organism: Human tissue/proteins tissue_or_cell_type: Macula and purified proteins experimental_model: Human macular protein purification and recombinant binding limitations: Binding affinity is assay-specific and does not quantify uptake or clinical benefit. exposure: Equilibrium binding and immunocytochemistry evidence_span: {"source_cache": "artifacts/zeaxanthin-research/15355982.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "6365b1d54aafda71be4dbf6c8e5252fa6ce0af3b808d9af6fe07c37ae188ea92", "start_char": 0, "end_char": 1907, "text_sha256": "6365b1d54aafda71be4dbf6c8e5252fa6ce0af3b808d9af6fe07c37ae188ea92"} [zeaxanthin-p15355982] Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. (2004). https://pubmed.ncbi.nlm.nih.gov/15355982/ DOI: 10.1074/jbc.m405334200
Complete structured claim and evidence
What acts on it
No significant GSTA1 transcriptional increase was detected in the phytochemical comparisons including DIM.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/dim-research/15672752.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "ccf97f305e0f4d5b98b172cef3a0875729e44b8f65420d87a6d725ec7207ca63", "start_char": 0, "end_char": 1560, "text_sha256": "ccf97f305e0f4d5b98b172cef3a0875729e44b8f65420d87a6d725ec7207ca63"}
- experimental_model
- Quantitative gene expression and protein assessment
- exposure
- DIM 10-50 micromolar
- limitations
- Cell-culture concentrations; fold mRNA induction is not the fold change in drug clearance in people.
- nutrient_topic
- Diindolylmethane (DIM) research collection; topical membership is not evidence of a direct dietary effect. · 3,3'-Diindolylmethane / DIM
- organism
- Primary human hepatocytes
- plain_language
- An enzyme response does not imply that every detoxification pathway rises together.
- primary_references
- [dim-p15672752] Phytochemical-induced changes in gene expression of carcinogen-metabolizing enzymes in cultured human primary hepatocytes. (2004). https://pubmed.ncbi.nlm.nih.gov/15672752/ DOI: 10.1080/00498250412331285481
- tissue_or_cell_type
- CYP and phase-II enzyme expression
Diindolylmethane (DIM): formation, receptor signaling, metabolism and drug interactions (2026-09-17) · lines 415–426
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Quantitative gene expression and protein assessment · source_derived_draft · unverified_draft
### dim-hepatocyte-gsta1-null No significant GSTA1 transcriptional increase was detected in the phytochemical comparisons including DIM. Condition category: normal nutrient_topic: Diindolylmethane (DIM) research collection; topical membership is not evidence of a direct dietary effect. plain_language: An enzyme response does not imply that every detoxification pathway rises together. organism: Primary human hepatocytes tissue_or_cell_type: CYP and phase-II enzyme expression experimental_model: Quantitative gene expression and protein assessment limitations: Cell-culture concentrations; fold mRNA induction is not the fold change in drug clearance in people. exposure: DIM 10-50 micromolar evidence_span: {"source_cache": "artifacts/dim-research/15672752.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "ccf97f305e0f4d5b98b172cef3a0875729e44b8f65420d87a6d725ec7207ca63", "start_char": 0, "end_char": 1560, "text_sha256": "ccf97f305e0f4d5b98b172cef3a0875729e44b8f65420d87a6d725ec7207ca63"} [dim-p15672752] Phytochemical-induced changes in gene expression of carcinogen-metabolizing enzymes in cultured human primary hepatocytes. (2004). https://pubmed.ncbi.nlm.nih.gov/15672752/ DOI: 10.1080/00498250412331285481
Complete structured claim and evidenceParallel differentiated Caco-2 experiments assigned GSTA1 induction to sulforaphane; perfusion with mixed extract increased GSTA1 mRNA 2.0-fold.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/12756216.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "98a56e8d1e84bffe3a4213eb3619d52869f85d999355d0e0f487d412149101af", "start_char": 0, "end_char": 1816, "text_sha256": "98a56e8d1e84bffe3a4213eb3619d52869f85d999355d0e0f487d412149101af"}
- experimental_model
- Human jejunal perfusion and parallel Caco-2 experiments
- exposure
- Dietary-concentration onion/broccoli extract perfusion
- limitations
- Human perfusion used a mixture; isolated Caco-2 comparisons help distinguish components. Local permeability is not systemic oral bioavailability.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human intestinal segment and human intestinal cell line
- plain_language
- The mixture and the isolated-component experiment provide different levels of attribution.
- primary_references
- [sulforaphane-p12756216] Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo. (2003). https://pubmed.ncbi.nlm.nih.gov/12756216/ DOI: 10.1124/dmd.31.6.805
- tissue_or_cell_type
- Absorption, luminal return and gene expression
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 411–422
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human jejunal perfusion and parallel Caco-2 experiments · source_derived_draft · unverified_draft
### sulforaphane-gsta1-induction Parallel differentiated Caco-2 experiments assigned GSTA1 induction to sulforaphane; perfusion with mixed extract increased GSTA1 mRNA 2.0-fold. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The mixture and the isolated-component experiment provide different levels of attribution. organism: Human intestinal segment and human intestinal cell line tissue_or_cell_type: Absorption, luminal return and gene expression experimental_model: Human jejunal perfusion and parallel Caco-2 experiments limitations: Human perfusion used a mixture; isolated Caco-2 comparisons help distinguish components. Local permeability is not systemic oral bioavailability. exposure: Dietary-concentration onion/broccoli extract perfusion evidence_span: {"source_cache": "artifacts/sulforaphane-research/12756216.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "98a56e8d1e84bffe3a4213eb3619d52869f85d999355d0e0f487d412149101af", "start_char": 0, "end_char": 1816, "text_sha256": "98a56e8d1e84bffe3a4213eb3619d52869f85d999355d0e0f487d412149101af"} [sulforaphane-p12756216] Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo. (2003). https://pubmed.ncbi.nlm.nih.gov/12756216/ DOI: 10.1124/dmd.31.6.805
Complete structured claim and evidenceFisetin reduced GSTA1 mRNA and protein in proliferating human Caco-2 cells.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human colorectal adenocarcinoma cell culture.
- limitations
- Cell state matters; the proposed binding-site location was based on modeling.
- nutrient_topic
- Fisetin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Fisetin
- plain_language
- Expression and direct enzyme inhibition are separate observations.
- primary_references
- The Interaction of the Flavonoid Fisetin with Human Glutathione Transferase A1-1. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33806779/ · DOI 10.3390/metabo11030190
Fisetin: metabolism, cell-state responses and cross-nutrient mechanisms (2026-09-19) · lines 96–102
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human colorectal adenocarcinoma cell culture. · source_derived_draft · unverified_draft
## fisetin-gsta1-expression Expression and direct enzyme inhibition are separate observations. Fisetin reduced GSTA1 mRNA and protein in proliferating human Caco-2 cells. Model: Human colorectal adenocarcinoma cell culture. Limitations: Cell state matters; the proposed binding-site location was based on modeling. Evidence access: Primary abstract The Interaction of the Flavonoid Fisetin with Human Glutathione Transferase A1-1. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33806779/ · DOI 10.3390/metabo11030190
Complete structured claim and evidenceFisetin reversibly inhibited purified human GSTA1-1 with IC50 1.2 +/- 0.1 micromolar; inhibition was mixed toward glutathione and noncompetitive toward CDNB.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Purified human enzyme kinetics.
- limitations
- CDNB probe assay, not proven human chemosensitization or global detoxification failure.
- nutrient_topic
- Fisetin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Fisetin
- plain_language
- A compound that supports a glutathione pool can also inhibit an enzyme using it.
- primary_references
- The Interaction of the Flavonoid Fisetin with Human Glutathione Transferase A1-1. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33806779/ · DOI 10.3390/metabo11030190
Fisetin: metabolism, cell-state responses and cross-nutrient mechanisms (2026-09-19) · lines 88–94
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Purified human enzyme kinetics. · source_derived_draft · unverified_draft
## fisetin-gsta1-inhibition A compound that supports a glutathione pool can also inhibit an enzyme using it. Fisetin reversibly inhibited purified human GSTA1-1 with IC50 1.2 +/- 0.1 micromolar; inhibition was mixed toward glutathione and noncompetitive toward CDNB. Model: Purified human enzyme kinetics. Limitations: CDNB probe assay, not proven human chemosensitization or global detoxification failure. Evidence access: Primary abstract The Interaction of the Flavonoid Fisetin with Human Glutathione Transferase A1-1. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33806779/ · DOI 10.3390/metabo11030190
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.